Si Bone Ownership

SIBN Stock  USD 12.56  0.27  2.20%   
Si Bone secures a total of 41.94 Million outstanding shares. The majority of Si Bone outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to take positions in Si Bone to benefit from reduced commissions. Thus, outside corporations are subject to a different set of regulations than regular investors in Si Bone. Please pay attention to any change in the institutional holdings of Si Bone as this could imply that something significant has changed or is about to change at the company. Also note that nearly four hundred six thousand eight hundred one invesors are currently shorting Si Bone expressing very little confidence in its future performance.
 
Shares in Circulation  
First Issued
2014-03-31
Previous Quarter
41.3 M
Current Value
41.7 M
Avarage Shares Outstanding
26.9 M
Quarterly Volatility
10.1 M
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Si Bone in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Si Bone, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
As of the 22nd of November 2024, Dividends Paid is likely to grow to about 3.3 M, while Dividend Paid And Capex Coverage Ratio is likely to drop (2.52). As of the 22nd of November 2024, Common Stock Shares Outstanding is likely to drop to about 22.4 M. In addition to that, Net Loss is likely to drop to about (57.9 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.

SIBN Stock Ownership Analysis

About 99.0% of the company shares are owned by institutional investors. The book value of Si Bone was at this time reported as 3.95. The company recorded a loss per share of 0.91. Si Bone had not issued any dividends in recent years. The entity had 1:70 split on the March 15, 2011. SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. The company was incorporated in 2008 and is headquartered in Santa Clara, California. Si Bone operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 352 people. To find out more about Si Bone contact Laura MBA at 408 207 0700 or learn more at https://si-bone.com.
Besides selling stocks to institutional investors, Si Bone also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Si Bone's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Si Bone's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Si Bone Quarterly Liabilities And Stockholders Equity

227 Million

Si Bone Insider Trades History

Roughly 2.0% of Si Bone are currently held by insiders. Unlike Si Bone's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Si Bone's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Si Bone's insider trades
 
Covid

SIBN Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Si Bone is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Si Bone backward and forwards among themselves. Si Bone's institutional investor refers to the entity that pools money to purchase Si Bone's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-06-30
M
Wellington Management Company Llp2024-06-30
993 K
Morgan Stanley - Brokerage Accounts2024-06-30
989.4 K
Geode Capital Management, Llc2024-06-30
894 K
Nuveen Asset Management, Llc2024-06-30
871.3 K
Next Century Growth Investors Llc2024-06-30
845.4 K
Kent Lake Capital Llc2024-06-30
800 K
Holocene Advisors, Lp2024-06-30
585.3 K
Impax Asset Management Group Plc2024-06-30
536.9 K
Brown Advisory Holdings Inc2024-09-30
M
Blackrock Inc2024-06-30
3.8 M
Note, although Si Bone's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Si Bone Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Si Bone insiders, such as employees or executives, is commonly permitted as long as it does not rely on Si Bone's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Si Bone insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Si Bone Corporate Filings

F4
20th of November 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
13A
14th of November 2024
The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934
ViewVerify
12th of November 2024
Other Reports
ViewVerify
F3
7th of August 2024
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify

Pair Trading with Si Bone

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Si Bone position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Si Bone will appreciate offsetting losses from the drop in the long position's value.

Moving against SIBN Stock

  0.58VMD Viemed HealthcarePairCorr
  0.41DOCS DoximityPairCorr
  0.4SSY SunLink Health SystemsPairCorr
The ability to find closely correlated positions to Si Bone could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Si Bone when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Si Bone - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Si Bone to buy it.
The correlation of Si Bone is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Si Bone moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Si Bone moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Si Bone can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Si Bone offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Si Bone's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Si Bone Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Si Bone Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Si Bone. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
To learn how to invest in SIBN Stock, please use our How to Invest in Si Bone guide.
You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Si Bone. If investors know SIBN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Si Bone listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.91)
Revenue Per Share
3.817
Quarterly Revenue Growth
0.186
Return On Assets
(0.12)
Return On Equity
(0.22)
The market value of Si Bone is measured differently than its book value, which is the value of SIBN that is recorded on the company's balance sheet. Investors also form their own opinion of Si Bone's value that differs from its market value or its book value, called intrinsic value, which is Si Bone's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Si Bone's market value can be influenced by many factors that don't directly affect Si Bone's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Si Bone's value and its price as these two are different measures arrived at by different means. Investors typically determine if Si Bone is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Si Bone's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.